We represented naviHealth’s Chief Executive Officer in connection with the company’s acquisition by Cardinal Health. naviHealth will be operated as a stand-alone subsidiary of Cardinal Health. naviHealth’s executive management team will continue to lead the business, and its principal investor, Welsh, Carson, Anderson & Stowe, along with management, will continue to have an ownership interest in the business. The transaction was valued at approximately $400 million.

naviHealth, a portfolio company of Welsh, Carson, Anderson & Stowe, is a leading convener for health systems in the Centers for Medicare and Medicaid Services’ Bundled Payments for Care Improvement initiative and also manages post-acute services for health plans. Cardinal Health, Inc. (NYSE: CAH) is a $103 billion health care services company that provides pharmaceuticals and medical products and services to more than 100,000 locations each day and is also an industry-leading direct-to-home medical supplies distributor.